Haemonetics Corporation (HAE)
NYSE: HAE · IEX Real-Time Price · USD
93.47
+0.14 (0.15%)
May 3, 2024, 10:30 AM EDT - Market open
Haemonetics Employees
Haemonetics had 3,034 employees on April 1, 2023. The number of employees increased by 213 or 7.55% compared to the previous year.
Employees
3,034
Change (1Y)
213
Growth (1Y)
7.55%
Revenue / Employee
$418,649
Profits / Employee
$41,719
Market Cap
4.75B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Apr 1, 2023 | 3,034 | 213 | 7.55% |
Apr 2, 2022 | 2,821 | 113 | 4.17% |
Apr 3, 2021 | 2,708 | -296 | -9.85% |
Mar 28, 2020 | 3,004 | -212 | -6.59% |
Mar 30, 2019 | 3,216 | 80 | 2.55% |
Mar 31, 2018 | 3,136 | 29 | 0.93% |
Apr 1, 2017 | 3,107 | -118 | -3.66% |
Apr 2, 2016 | 3,225 | -158 | -4.67% |
Mar 28, 2015 | 3,383 | -399 | -10.55% |
Mar 29, 2014 | 3,782 | 219 | 6.15% |
Mar 30, 2013 | 3,563 | 1,226 | 52.46% |
Mar 31, 2012 | 2,337 | 136 | 6.18% |
Apr 2, 2011 | 2,201 | -126 | -5.41% |
Apr 3, 2010 | 2,327 | 311 | 15.43% |
Mar 28, 2009 | 2,016 | 141 | 7.52% |
Mar 29, 2008 | 1,875 | 49 | 2.68% |
Mar 31, 2007 | 1,826 | 165 | 9.93% |
Apr 1, 2006 | 1,661 | 161 | 10.73% |
Apr 2, 2005 | 1,500 | 0 | - |
Apr 3, 2004 | 1,500 | 3 | 0.20% |
Mar 29, 2003 | 1,497 | -1 | -0.07% |
Mar 30, 2002 | 1,498 | 141 | 10.39% |
Mar 31, 2001 | 1,357 | 29 | 2.18% |
Apr 1, 2000 | 1,328 | -1 | -0.08% |
Apr 3, 1999 | 1,329 | -67 | -4.80% |
Mar 28, 1998 | 1,396 | -130 | -8.52% |
Mar 29, 1997 | 1,526 | 275 | 21.98% |
Mar 30, 1996 | 1,251 | -31 | -2.42% |
Mar 30, 1995 | 1,282 | 173 | 15.60% |
Mar 30, 1994 | 1,109 | 107 | 10.68% |
Mar 30, 1993 | 1,002 | 37 | 3.83% |
Mar 30, 1992 | 965 | 42 | 4.55% |
Mar 30, 1991 | 923 | 113 | 13.95% |
Mar 30, 1990 | 810 | 68 | 9.16% |
Mar 30, 1989 | 742 | -38 | -4.87% |
Mar 30, 1988 | 780 | 155 | 24.80% |
Mar 30, 1987 | 625 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Bausch + Lomb | 13,300 |
Organon & Co. | 10,000 |
Doximity | 977 |
Glaukos | 907 |
Lantheus Holdings | 834 |
BridgeBio Pharma | 550 |
CRISPR Therapeutics AG | 407 |
Halozyme Therapeutics | 373 |
HAE News
- 22 days ago - Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 - PRNewsWire
- 4 weeks ago - Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge - PRNewsWire
- 4 weeks ago - Haemonetics Corporation Completes Acquisition of Attune Medical - PRNewsWire
- 2 months ago - Haemonetics Announces Definitive Agreement to Acquire Attune Medical - PRNewsWire
- 2 months ago - Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference - PRNewsWire
- 2 months ago - Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day - PRNewsWire
- 3 months ago - Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website - PRNewsWire
- 4 months ago - Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024 - PRNewsWire